FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4298088294> ?p ?o ?g. }

• W4298088294 endingPage "1167" @default.
• W4298088294 startingPage "1156" @default.
• W4298088294 abstract "Aims Hip fracture commonly affects the frailest patients, of whom many are care-dependent, with a disproportionate risk of contracting COVID-19. We examined the impact of COVID-19 infection on hip fracture mortality in England. Methods We conducted a cohort study of patients with hip fracture recorded in the National Hip Fracture Database between 1 February 2019 and 31 October 2020 in England. Data were linked to Hospital Episode Statistics to quantify patient characteristics and comorbidities, Office for National Statistics mortality data, and Public Health England’s SARS-CoV-2 testing results. Multivariable Cox regression examined determinants of 90-day mortality. Excess mortality attributable to COVID-19 was quantified using Quasi-Poisson models. Results Analysis of 102,900 hip fractures (42,630 occurring during the pandemic) revealed that among those with COVID-19 infection at presentation (n = 1,120) there was a doubling of 90-day mortality; hazard ratio (HR) 2.09 (95% confidence interval (CI) 1.89 to 2.31), while the HR for infections arising between eight and 30 days after presentation (n = 1,644) the figure was greater at 2.51 (95% CI 2.31 to 2.73). Malnutrition (1.45 (95% CI 1.19 to 1.77)) and nonoperative treatment (2.94 (95% CI 2.18 to 3.95)) were the only modifiable risk factors for death in COVID-19-positive patients. Patients who had tested positive for COVID-19 more than two weeks prior to hip fracture initially had better survival compared to those who contracted COVID-19 around the time of their hip fracture; however, survival rapidly declined and by 365 days the combination of hip fracture and COVID-19 infection was associated with a 50% mortality rate. Between 1 January and 30 June 2020, 1,273 (99.7% CI 1,077 to 1,465) excess deaths occurred within 90 days of hip fracture, representing an excess mortality of 23% (99.7% CI 20% to 26%), with most deaths occurring within 30 days. Conclusion COVID-19 infection more than doubles the rate of early hip fracture mortality. Those contracting infection between 8 and 30 days after initial presentation are at even higher mortality risk, signalling the potential for targeted interventions during this period to improve survival. Cite this article: Bone Joint J 2022;104-B(10):1156–1167." @default.
• W4298088294 created "2022-10-01" @default.
• W4298088294 creator A5001775749 @default.
• W4298088294 creator A5005539896 @default.
• W4298088294 creator A5007355607 @default.
• W4298088294 creator A5012710719 @default.
• W4298088294 creator A5013384461 @default.
• W4298088294 creator A5015477612 @default.
• W4298088294 creator A5016621670 @default.
• W4298088294 creator A5019514344 @default.
• W4298088294 creator A5022522503 @default.
• W4298088294 creator A5055791988 @default.
• W4298088294 creator A5079220244 @default.
• W4298088294 creator A5082532574 @default.
• W4298088294 date "2022-10-01" @default.
• W4298088294 modified "2023-10-18" @default.
• W4298088294 title "The impact of COVID-19 on mortality after hip fracture" @default.
• W4298088294 cites W1963710671 @default.
• W4298088294 cites W1981384212 @default.
• W4298088294 cites W2040043381 @default.
• W4298088294 cites W2066801367 @default.
• W4298088294 cites W2096986810 @default.
• W4298088294 cites W2097501252 @default.
• W4298088294 cites W2110396808 @default.
• W4298088294 cites W2113130543 @default.
• W4298088294 cites W2123746917 @default.
• W4298088294 cites W2133488558 @default.
• W4298088294 cites W2158748006 @default.
• W4298088294 cites W2185527326 @default.
• W4298088294 cites W2256596564 @default.
• W4298088294 cites W2529336843 @default.
• W4298088294 cites W2568120501 @default.
• W4298088294 cites W2588302697 @default.
• W4298088294 cites W2602904671 @default.
• W4298088294 cites W2615179878 @default.
• W4298088294 cites W2802067770 @default.
• W4298088294 cites W3014360138 @default.
• W4298088294 cites W3080487846 @default.
• W4298088294 cites W3087720088 @default.
• W4298088294 cites W3088793359 @default.
• W4298088294 cites W3093730655 @default.
• W4298088294 cites W3095531667 @default.
• W4298088294 cites W3100280467 @default.
• W4298088294 cites W3108582220 @default.
• W4298088294 cites W3116943844 @default.
• W4298088294 cites W3124774867 @default.
• W4298088294 cites W3129748389 @default.
• W4298088294 cites W3158323486 @default.
• W4298088294 cites W3162691935 @default.
• W4298088294 cites W3164888076 @default.
• W4298088294 cites W4213164337 @default.
• W4298088294 cites W4213321637 @default.
• W4298088294 doi "https://doi.org/10.1302/0301-620x.104b10.bjj-2022-0082.r1" @default.
• W4298088294 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36177635" @default.
• W4298088294 hasPublicationYear "2022" @default.
• W4298088294 type Work @default.
• W4298088294 citedByCount "4" @default.
• W4298088294 countsByYear W42980882942022 @default.
• W4298088294 countsByYear W42980882942023 @default.
• W4298088294 crossrefType "journal-article" @default.
• W4298088294 hasAuthorship W4298088294A5001775749 @default.
• W4298088294 hasAuthorship W4298088294A5005539896 @default.
• W4298088294 hasAuthorship W4298088294A5007355607 @default.
• W4298088294 hasAuthorship W4298088294A5012710719 @default.
• W4298088294 hasAuthorship W4298088294A5013384461 @default.
• W4298088294 hasAuthorship W4298088294A5015477612 @default.
• W4298088294 hasAuthorship W4298088294A5016621670 @default.
• W4298088294 hasAuthorship W4298088294A5019514344 @default.
• W4298088294 hasAuthorship W4298088294A5022522503 @default.
• W4298088294 hasAuthorship W4298088294A5055791988 @default.
• W4298088294 hasAuthorship W4298088294A5079220244 @default.
• W4298088294 hasAuthorship W4298088294A5082532574 @default.
• W4298088294 hasConcept C126322002 @default.
• W4298088294 hasConcept C144024400 @default.
• W4298088294 hasConcept C149923435 @default.
• W4298088294 hasConcept C187212893 @default.
• W4298088294 hasConcept C201903717 @default.
• W4298088294 hasConcept C207103383 @default.
• W4298088294 hasConcept C2776541429 @default.
• W4298088294 hasConcept C2778885795 @default.
• W4298088294 hasConcept C2779134260 @default.
• W4298088294 hasConcept C2908647359 @default.
• W4298088294 hasConcept C3008058167 @default.
• W4298088294 hasConcept C44249647 @default.
• W4298088294 hasConcept C50382708 @default.
• W4298088294 hasConcept C524204448 @default.
• W4298088294 hasConcept C71924100 @default.
• W4298088294 hasConcept C72563966 @default.
• W4298088294 hasConcept C73269764 @default.
• W4298088294 hasConcept C99454951 @default.
• W4298088294 hasConceptScore W4298088294C126322002 @default.
• W4298088294 hasConceptScore W4298088294C144024400 @default.
• W4298088294 hasConceptScore W4298088294C149923435 @default.
• W4298088294 hasConceptScore W4298088294C187212893 @default.
• W4298088294 hasConceptScore W4298088294C201903717 @default.
• W4298088294 hasConceptScore W4298088294C207103383 @default.
• W4298088294 hasConceptScore W4298088294C2776541429 @default.
• W4298088294 hasConceptScore W4298088294C2778885795 @default.

• next